Cargando…
Liposomal PHD2 Inhibitors and the Enhanced Efficacy in Stabilizing HIF-1α
Prolyl hydroxylase domain-containing protein 2 (PHD2) inhibition, which stabilizes hypoxia-inducible factor (HIF)-1α and thus triggers adaptation responses to hypoxia in cells, has become an important therapeutic target. Despite the proven high potency, small-molecule PHD2 inhibitors such as IOX2 ma...
Autores principales: | Jian, Cheng-Bang, Yu, Xu-En, Gao, Hua-De, Chen, Huai-An, Jheng, Ren-Hua, Chen, Chong-Yan, Lee, Hsien-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746909/ https://www.ncbi.nlm.nih.gov/pubmed/35010112 http://dx.doi.org/10.3390/nano12010163 |
Ejemplares similares
-
Phospholipase D1 protein coordinates dynamic assembly of HIF-1α-PHD-VHL to regulate HIF-1α stability
por: Park, Mi Hee, et al.
Publicado: (2014) -
Cystathione β-synthase regulates HIF-1α stability through persulfidation of PHD2
por: Dey, Anindya, et al.
Publicado: (2020) -
LRP5 Regulates HIF-1α Stability via Interaction with PHD2 in Ischemic Myocardium
por: Ju, Sujin, et al.
Publicado: (2021) -
Loss of miR-145-5p Causes Ceruloplasmin Interference with PHD-Iron Axis and HIF-2α Stabilization in Lung Adenocarcinoma-Mediated Angiogenesis
por: Tsai, Ying-Ming, et al.
Publicado: (2020) -
Roxadustat, a HIF-PHD inhibitor with exploitable potential on diabetes-related complications
por: Fang, Tingting, et al.
Publicado: (2023)